2017-10-17 - OBSERVABLE Face-to-face Meeting, Bratislava, Slovakia

Date

2017-10-17 07.00 - 10.00 UTC

@Jim Campbell

@Jay Lyle

@Deborah Drake (Unlicensed)

@Laszlo Igali (Unlicensed)

Matthew Manning

@Brian Carlsen

@Former user (Deleted)

@Brandon Ulrich (Unlicensed)

@Farzaneh Ashrafi

@Michael Osborne (Unlicensed) (Zoom)

@gansel (Deactivated) (Zoom)

@Daniel Karlsson

@Jostein Ven (Unlicensed)

@Kath Priest (Zoom)

Item	Description	Owner	Notes	Action

Item	Description	Owner	Notes
1	Welcome & apologies	@Daniel Karlsson
2	Conflicts of interest	@Daniel Karlsson	None stated
3	Process observables attributes	@Daniel Karlsson	Including Coagulation observables Rate ratios, e.g. 50410-0 - Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid:Ratio:Pt:PPP:Qn:Coag NPU18363 Pt(U)—Pyridinoline/Creatininium; subst.rate ratio(proc.) = ? × 10^-6
4	LOINC collaboration	@Farzaneh Ashrafi	Discussion items posted on OIMP discussion board: Age Likelihood
5	Pathology observables	@Jim Campbell
6	Observables vs. Findings	@Daniel Karlsson @Former user (Deleted)	See discussion and slides from @Former user (Deleted) attached on this page
7	Next meeting(s)	@Daniel Karlsson	Next meeting is 2017-11-06 20.00 UTC (Remember daylight saving time change)
8	AOB	@Daniel Karlsson

	File	Modified
Labels No labels Preview View	Microsoft Powerpoint Presentation Observables_vs_Clinical_findings_ihtsdo_format.pptx	2017-Oct-01 by Daniel Karlsson
Labels No labels Preview View	Microsoft Powerpoint Presentation Publishing Observables Development.pptx Advice requested on publication artifacts	2017-Oct-17 by Jim Campbell
Labels No labels Preview View	PDF File Presentation for OIMP@Business meetings Oct 2017.pptx.pdf	2017-Oct-17 by Farzaneh Ashrafi

Download All